Basic Information
| LncRNA/CircRNA Name | H19 |
| Synonyms | NA |
| Region | GRCh38_11:1995176-2001470 |
| Ensemble | ENSG00000130600 |
| Refseq | NR_002196 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | papillary thyroid cancer |
| ICD-0-3 | NA |
| Methods | qPCR |
| Sample | papillary thyroid carcinoma tissues, benign thyroid nodes tissues |
| Expression Pattern | down-regulated |
| Function Description | Low expression of H19 was associated with patient`s age, tumor size, extrathyroid extension, pathological lateral node metastasis (pN1b), histological aggressive type and poorer disease-free survival (p < 0.0001). |
| Pubmed ID | 31403942 |
| Year | 2019 |
| Title | Long non-coding RNA H19 may be a marker for prediction of prognosis in the follow-up of patients with papillary thyroid cancer |
External Links
| Links for H19 | GenBank HGNC NONCODE |
| Links for papillary thyroid cancer | OMIM COSMIC |